Foresite Capital Management III, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 147 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.

Quarter-by-quarter ownership
Foresite Capital Management III, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$4,502,000
+19.4%
265,6050.0%0.99%
+22.3%
Q2 2018$3,772,000
+28.5%
265,605
+72.0%
0.81%
+26.9%
Q1 2018$2,935,000
+116.6%
154,462
+0.3%
0.64%
+44.5%
Q2 2017$1,355,000
-58.9%
154,000
-71.7%
0.44%
-82.6%
Q1 2016$3,296,000544,8162.55%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Alexandria Capital, LLC 968,505$12,135,0001.23%
Golden State Equity Partners 126,608$1,586,0000.90%
McGuire Investment Group, LLC 272,801$3,418,0000.72%
Lombard Odier Asset Management (Switzerland) SA 848,429$10,631,0000.70%
Rhenman & Partners Asset Management AB 765,000$9,585,0000.67%
EMC Capital Management 72,061$903,0000.64%
WASATCH ADVISORS LP 10,328,423$129,415,0000.58%
Ceeto Capital Group, LLC 74,000$927,0000.45%
Fort Sheridan Advisors LLC 75,945$952,0000.38%
Vanguard Capital Wealth Advisors 34,580$388,679,0000.33%
View complete list of SANGAMO THERAPEUTICS INC shareholders